Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01XRW
|
|||
| Drug Name |
PMID27977313-Compound-31
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H15Cl2NO3
|
|||
| Canonical SMILES |
CCC1=C(C(=CC=C1)CC)NC(=O)C(=C(C(=O)O)Cl)Cl
|
|||
| InChI |
1S/C14H15Cl2NO3/c1-3-8-6-5-7-9(4-2)12(8)17-13(18)10(15)11(16)14(19)20/h5-7H,3-4H2,1-2H3,(H,17,18)(H,19,20)/b11-10+
|
|||
| InChIKey |
JDSFJBVJTZVNIT-ZHACJKMWSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytoplasmic thioredoxin reductase (TXNRD1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cytoplasmic thioredoxin reductase (TXNRD1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.